Status:

UNKNOWN

Psychobiological Characterization of Depression in Hepatitis C

Lead Sponsor:

Centro Hospitalar Lisboa Norte

Conditions:

Depression

Hepatitis c

Eligibility:

All Genders

18-65 years

Brief Summary

The aim of this study is to do an evaluation of the clinical profile of depression in HCV patients (newly diagnosed and treatment naïve), and in these same individuals, 24 weeks after the beginning of...

Detailed Description

The World Health Organization (WHO) estimates that about 3% of the world population (170 million people) is infected with the hepatitis C virus (HCV). In Portugal, there were an estimated 150.000 case...

Eligibility Criteria

Inclusion

  • minimum education;
  • ages between 18 and 65 years old;
  • with diagnosis of Hepatitis C for at least 6 months, newly diagnosed and treatment naive;
  • and diagnosis of Major Depression for the control group.

Exclusion

  • consumption of opiates, cocaine or other recreational drugs in the 6 months prior to the beginning of the research;
  • use of anti-inflammatory drugs and antidepressants;
  • history of neurological, infectious or tumoral pathology, at SNC level;
  • severe physical deterioration incompatible with the situation being evaluated.

Key Trial Info

Start Date :

January 1 2012

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2015

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT01492478

Start Date

January 1 2012

End Date

December 1 2015

Last Update

December 15 2011

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Faculty of Medicice of Lisbon

Lisbon, Portugal